(Q52596224)
Statements
Safety, tolerability, and pharmacokinetics of SPL7013 gel (VivaGel): a dose ranging, phase I study (English)
John M Kaldor
Iona Y Millwood
John O'Loughlin
Helen M McDonald
Clare F Price
Jeremy R A Paull
1 February 2010
37
2
100-104